Supplemental Appendix B. Distribution of PSA and Gleason score All RP RT ADT AS p (N=1,088) (N=661) (N=181) (N=105) (N=141) PSA, (median, IQR) 6.2 5.6 8.9 23.6 6.0 <0.0001 (4.7-10) (4.4-7.8) (5.7-15.4) (10.6-44) (4.8-8.5) n (row %) Gleason score <0.0001 4-6 602 392 (65.1) 82 (13.6) 11 (1.8) 117 (19.4) 3+4 277 177 (63.9) 58 (20.9) 27 (9.8) 15 (5.4) 4+3 117 65 (55.6) 23 (19.7) 25 (21.4) 4 (3.4) 8 64 20 (31.3) 14 (21.9) 27 (42.2) 3 (4.7) 9-10 27 7 (25.9) 4 (14.8) 14 (51.9) 2 (7.4) Note: PSA was not available for 9 patients; Gleason score was not available for 1 patient.
Supplemental Appendix B. Distribution of PSA and Gleason score All (N=1,088) RP (N=661) RT (N=181) ADT (N=105) AS (N=141) p PSA, (median, IQR) 6.2 (4.7-10) 5.6 (4.4-7.8) 8.9 (5.7-15.4) 23.6 (10.6-44) 6.0 (4.8-8.5) <0.0001 n (row %) Gleason score 4-6 3+4 4+3 8 9-10 602 277 117 64 27 392 (65.1) 177 (63.9) 65 (55.6) 20 (31.3) 7 (25.9) 82 (13.6) 58 (20.9) 23 (19.7) 14 (21.9) 4 (14.8) 11 (1.8) 27 (9.8) 25 (21.4) 27 (42.2) 14 (51.9) 117 (19.4) 15 (5.4) 4 (3.4) 3 (4.7) 2 (7.4) <0.0001 Note: PSA was not available for 9 patients; Gleason score was not available for 1 patient.
1-s2.0-S2452109417302312-mmc1.docx